Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department
Covid19
About this trial
This is an interventional diagnostic trial for Covid19 focused on measuring Performance of test
Eligibility Criteria
Inclusion Criteria:
*Children under 18 years old requiring an RT-PCR Covid-19 defined according to the algorithm in force at CHI Créteil and which follows the recommendations of the GPIP and the SFP only for symptomatic children :
- Symptomatic children more then 6 years old: cough, and/or fever, and/or digestive disorders unless a diagnosis of another infectious disease is made with certainty (ex Scarlet fever, angina with AMS, enterovirus, urinary tract infections, chickenpox)
- Symptomatic children under 6 years old:
In case of hospitalization or symptoms severe enough to warrant further exploration.
Or who has had a proven contact with a COVID case. Or in contact at home with people considered at risk for SARS-CoV2 infection. Or whose symptoms do not improve after 3 days.
--Febrile children under 3 months old
- Express agreement of one of the parents present, the presence of only one of the two parents being recommanded in the current context
- Affiliated with the Social Security plan
Exclusion Criteria:
Refusal of one of the parents or child to participate in the protocol
Sites / Locations
- Centre hospitalier intercommunal de Créteil
- Cabinet de ville
- Cabinet Dr Cohen
- Cabinet de ville 13 Villa Beauséjour
Arms of the Study
Arm 1
Other
Test rapid antigenic and Test RT-PCR